Clinical trial
Phase I/II Study of Carboplatin in Association With Weekly Oral Topotecan in Patients With Metastatic or Recurrent Cervical Cancer
NCT00807079 is registered in ClinicalTrials.gov with ARCAGY/ GINECO GROUP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Study of Carboplatin in Association With Weekly Oral Topotecan in Patients With Metastatic or Recurrent Cervical Cancer
- Lead sponsor
- ARCAGY/ GINECO GROUP
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- Not reported
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer